在乳腺癌治疗中局部应用的库尔库和奎尔丁加载纳米质凝配方
Meena Tilawat1,2, Smita Bonde1,3
1SVKM's NMIMS, School of Pharmacy and Technology Management, Shirpur Campus, Maharashtra, India.
Heliyon
|December 7, 2023
概括
这项研究开发了一种新的黄素和氨酸纳米合物凝,用于局部乳腺癌治疗. 这种配方增强了生物可用性,并显示出显著的抗癌活性,提供了一个有前途的辅助疗法.
科学领域:
- 药理学 药理学是指药理学的学科.
- 材料科学 材料科学 材料科学
- 在瘤学瘤学.
背景情况:
- 乳腺癌手术后,化疗是标准的,以消除残留细胞并防止复发.
- 黄素和青素是具有抗癌特性的黄类化合物,但由于溶解性和生物可用性差,它们的临床使用受到限制.
- 纳米质提供了一种新的输送系统,以克服这些限制,以提高局部药物输送.
研究的目的:
- 为了制定和表征黄素和氨酸载荷的纳米质物成一种凝用于局部乳腺癌辅助疗法.
- 评估开发的配方的体外药物释放特征和细胞毒性作用.
- 评估这种新型配方作为乳腺癌改善治疗选择的潜力.
主要方法:
- 黄素和氨酸被装入纳米质物中,然后将其配制成凝.
- 描述包括粒子大小,泽塔潜力,封装效率和药物释放研究.
- 在体外细胞毒性使用MTT试验进行评估,比较纳米质凝与对照剂和其他配方.
主要成果:
- 青素和黄素纳米合物表现出有利的物理化学特性 (例如,颗粒大小~328 nm,高封装效率>82%).
- 纳米质凝在体外显示有控制的药物释放,氨酸和黄素的释放分别达到78%和77%.
- 与对照剂和其他配方相比,MTT测定显示黄素和氨酸载纳米质物对癌细胞的最大抑制.
结论:
- 开发的黄素和氨酸载荷的纳米质凝是局部乳腺癌辅助治疗的有希望的配方.
- 这种配方有效地提高了黄素和青素的生物可用性和治疗效果.
- 纳米质凝是乳腺癌治疗中局部应用的优越选择,原因是改善了药物输送和增强了抗癌活性.
更多相关视频
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
11.0K
08:39Magnetic and Thermal-sensitive PolyN-isopropylacrylamide-based Microgels for Magnetically Triggered Controlled Release
Published on: July 4, 2017
9.0K
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
168
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
168
